Peer Review History

Original SubmissionJune 5, 2024
Decision Letter - Anselme Shyaka, Editor

PONE-D-24-21886Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda.PLOS ONE

Dear Dr. Kankya,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Additional Editor Comments:

In addition to specific comments from three reviewers, please:

- Modify the figure 1. I advise you to use freely accessible layers and Geographic Information System software to generate your own map showing precise study sites.

- Line 202-203: Where is the final list of prioritized zoonoses

- 375 – 387: What is the relevance of this paragraph to your study findings?

- Check for the manuscript for the many typos. Examples are:

o Line 125: Missing word in the sentence ending with “Lake Albert to the…”

o Line 126: The sentence is incomplete

o 196-197: Themes c and d are the same.

o Line 202: Is Swine fever a zoonoses? Clarify why it was included

o 306-307: “Importance of” is repeated twice

Please submit your revised manuscript by Aug 24 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Anselme Shyaka, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

We acknowledge funding obtained from Norwegian Agency for Development Cooperation (NORAD) through the NORHED-II Program and the project Climate Change and Infectious Diseases - A One Health Approach (CIDIMOH), grant number 68802. 

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

The authors wish to thank the District Veterinary Team and District Health Team of Bundibugyo district, the participants of the study and funders of this study.

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

We acknowledge funding obtained from Norwegian Agency for Development Cooperation (NORAD) through the NORHED-II Program and the project Climate Change and Infectious Diseases - A One Health Approach (CIDIMOH), grant number 68802. 

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

6. We note that you have referenced "S. N. Musila, D. K. Mafigiri and M. Schmidt-sane" which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (S. N. Musila, D. K. Mafigiri and M. Schmidt-sane [Submitted]) as detailed online in our guide for authors

http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style

7. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1:  Authors addressed clearly aspects related on the Gender perspectives on zoonotic disease epidemiology using a SWOT analysis in Bundibugyo a district of Uganda. The methodology is fitting the results presented in the manuscript and the topic is actually relevant for the control of zoonotic diseases in the country an the sub-region.

Therefore some comments are proposed to improve this manuscript:

>Line 73: Better to put a citation (s) for this sentence

>Line 76: remove the coma at the beginning of the sentence

>Line 87: In my opinion, not all men are playing such role except where this gender role can be played, so reformulate the sentence.

>Line 137: Is it possible to make clear the district of study by extracting it from the map of Uganda. There the borders could be well visible.

>147: make a correction on this sentence : All participants mostly understood English.

How about to include also participants who didn't get a formal education; because zoonotic diseases mitigation can not be limited to knowledge. Illiteracy can maybe play a role of their spread and therefore constitute a weakness for their control. What do you think on this?

>Line 288: diseases

>Line 310: In this paragraph, the capture on how diseases manifest and traverse along lines of gender is not clearly stated.

Also, Check if some of the opportunities although mentioned by participants are not likely to be part of the Strength for zoonotic diseases management, prevention and control

>Line 435: remove the citation in the conclusion

Reviewer #2:  - there were some unclear sentences with some run-ons, that i've noted in the attachment. Suggestions on improving sentence construction were also made to clarify some statements

- examples of questions from the IDI, KII, and FGD would be helpful, if authors will oblige

- suggest for the authors to proofread the entire report again, as the abstract has an obvious mistake (opportunities mentioned twice, no threats)

Reviewer #3:  The study explores gender perspectives on zoonotic disease epidemiology

using a (strength, weakness, opportunities and threats) SWOT analysis in Bundibugyo district in Uganda.

The study adopts the SWOT analysis. While the authors have made good effort to do so across the key elements, there is need for further clarity within each SWOT element in the discussion session. This should be done by highlighting the gendered aspects in each element e.g. in discussing a strength, discuss how it is a strength for men, for women and why.

The authors should also look within the uploaded document and address specific comments mentioned.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Esther Leah Achandi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-24-21886 - with comments.pdf
Attachment
Submitted filename: PONE-D-24-21886_reviewer_7072024.pdf
Revision 1

Makerere University

School of biosecurity, ecosystems and veterinary Public Health

26th July 2024

To The Editor

Plos One

We are grateful to the editor for giving us the opportunity to edit our manuscript titled “Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda.” We also appreciate the peer reviewers’ efforts for their insights, which have significantly improved the quality of our manuscript.

We have addressed the reviewers’ comments to the best of our ability, hence would like to submit the revised manuscript.

Comment Response

Editor

Modify the figure 1. I advise you to use freely accessible layers and Geographic Information System software to generate your own map showing precise study sites. This has been edited to highlight the district of study

Line 202-203: Where is the final list of prioritized zoonoses All zoonoses highlighted were mentioned by participants as diseases that are of priority to them.

375 – 387: What is the relevance of this paragraph to your study findings? This shows the gender roles men and women play in prevention of zoonotic diseases from both animals and humans and how exposure to this knowledge has helped them.

Check for the manuscript for the many typos. Examples are:

o Line 125: Missing word in the sentence ending with “Lake Albert to the…” Thank you for this comment. This has been edited as per the comment given.

Line 126: The sentence is incomplete The sentence has been completed.

196-197: Themes c and d are the same.

This has been edited to include community strength for zoonotic disease management as theme c

Line 202: Is Swine fever a zoonoses? Clarify why it was included This has been removed as per the comment since it’s not a zoonotic disease.

306-307: “Importance of” is repeated twice Thank you for this comment. This has been edited.

Reviewer 1

Authors addressed clearly aspects related on the Gender perspectives on zoonotic disease epidemiology using a SWOT analysis in Bundibugyo a district of Uganda. The methodology is fitting the results presented in the manuscript and the topic is actually relevant for the control of zoonotic diseases in the country an the sub-region.

Therefore some comments are proposed to improve this manuscript:

>Line 73: Better to put a citation (s) for this sentence The citation has been included. Thank you for the comment.

>Line 76: remove the coma at the beginning of the sentence This has been removed as per the comment. Thank you for the comment.

>Line 87: In my opinion, not all men are playing such role except where this gender role can be played, so reformulate the sentence. Thank you for the comment. This statement has been reformulated.

>Line 137: Is it possible to make clear the district of study by extracting it from the map of Uganda. There the borders could be well visible. Thank you for the comment. The map has been deleted form this article.

>147: make a correction on this sentence: All participants mostly understood English. This has been edited as per the comment given.

How about to include also participants who didn't get a formal education, because zoonotic diseases mitigation cannot be limited to knowledge. Illiteracy can maybe play a role of their spread and therefore constitute a weakness for their control. What do you think on this? Thank you for this comment. Most participants understand selected for this study were found to understand English as well however originally during the selection knowing English was not a selection criterion.

>Line 288: diseases Thank you for the comment. This has been edited to include zoonotic diseases.

>Line 310: In this paragraph, the capture on how diseases manifest and traverse along lines of gender is not clearly stated.

Thanks for the comment. This quote was aimed to show how the women prevent the diseases by having the prevention strategies in place to prevent the spread of the zoonotic/infectious diseases. I see gender inclusiveness through prevention from homes.

Also, Check if some of the opportunities although mentioned by participants are not likely to be part of the Strength for zoonotic diseases management, prevention and control The strength for zoonotic disease management, prevention and control is looking at what are the advantages and what is working well within the community. Opportunities for communities in management leaveraged on what prizes are within reach for the community to dwell on.

>Line 435: remove the citation in the conclusion Thank you for the comment. This has been removed.

Reviewer 2

There were some unclear sentences with some run-ons, that i've noted in the attachment. Suggestions on improving sentence construction were also made to clarify some statements

- examples of questions from the IDI, KII, and FGD would be helpful, if authors will oblige

Thank you for the comment. The tool has been uploaded.

- suggest for the authors to proofread the entire report again, as the abstract has an obvious mistake (opportunities mentioned twice, no threats) Thanks for the comment. The repetition has been edited and all included.

Reviewer 3

The study explores gender perspectives on zoonotic disease epidemiology

using a (strength, weakness, opportunities and threats) SWOT analysis in Bundibugyo district in Uganda. The study adopts the SWOT analysis. While the authors have made a good effort to do so across the key elements, there is need for further clarity within each SWOT element in the discussion session. This should be done by highlighting the gendered aspects in each element e.g. in discussing a strength, discuss how it is a strength for men, for women and why.

The authors should also look within the uploaded document and address specific comments mentioned. Thank you for the comment. This has been highlighted in the whole discussion how it is gender related within each SWOT. All comments have been addressed and worked on.

Yours Sincerely

Clovice Kankya

Attachments
Attachment
Submitted filename: rebuttal.docx
Decision Letter - Ayi Vandi Kwaghe, Editor

PONE-D-24-21886R1Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda.PLOS ONE

Dear Dr. Kankya,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Please ensure that your decision is justified on PLOS ONE’s publication criteria  and not, for example, on novelty or perceived impact.

For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. 

==============================

Please submit your revised manuscript by May 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ayi Vandi Kwaghe, D.V.M., M.V.Sc., P.G.D.E. Ph.D., MPH, FETP

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors touched a topic addressing the Gender perspectives on zoonotic disease epidemiology; A Strength Weakness

Opportunities Threats analysis in Bundibugyo district, Uganda. They responded correctly all the comments from the reviewers.

Reviewer #4: The authors of the manuscript entitled: Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda, have improved the presentation of the work by addressing all comments from reviewers.

This paper would have been beneficial if a list of zoonotic diseases mentioned by the respondents are provided before the ranking?. Whereas SWOT approach was used, it not very clear how it was deployed across KIIs, Indepth interviews and FGDs (This could be provided as supplementary files including checklists that were used). It was not clear on who conducted different interviews, and which language was used.

In the methods sections, 7 sub-counties were considered in the study area, it is not clear on how the respondents for different categories of interviews were selected in 7- sub-counties (A supplementary table) may be need to clarify the approaches used in the selection of respondents.

Some sections in the discussion seem to divert from the subject matter and introduce most the previously reported assertions

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #4: Yes:  Lawrence Mugisha

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 2

Makerere University

School of biosecurity, ecosystems and veterinary Public Health

10th April 2024

To The Editor

Plos One

We are grateful to the editor for giving us the opportunity to edit our manuscript titled “Gender perspectives on zoonotic disease epidemiology: A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda.” We also appreciate the peer reviewers’ efforts for their insights, which have significantly improved the quality of our manuscript.

We have addressed the reviewers’ comments to the best of our ability, hence would like to submit the revised manuscript.

Comment Response

Reviewer #1

Authors touched a topic addressing the Gender perspectives on zoonotic disease epidemiology; A Strength Weakness

Opportunities Threats analysis in Bundibugyo district, Uganda. They responded correctly all the comments from the reviewers.

Thank you for the feedback, we are really grateful.

Reviewer #4

The authors of the manuscript entitled: Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda, have improved the presentation of the work by addressing all comments from reviewers.

This paper would have been beneficial if a list of zoonotic diseases mentioned by the respondents are provided before the ranking?

Thank you for the comment, these have been included in the manuscript.

Whereas SWOT approach was used, it not very clear how it was deployed across KIIs, In-depth interviews and FGDs (This could be provided as supplementary files including checklists that were used). It was not clear on who conducted different interviews, and which language was used.

Thank you for the comment. The tool has been included a supplementary material for each of the categories of KIIs, IDIs and FGDs.

In the methods sections, 7 sub-counties were considered in the study area, it is not clear on how the respondents for different categories of interviews were selected in 7- sub-counties (A supplementary table) may be need to clarify the approaches used in the selection of respondents. This is a great comment. The participants recruitment criteria were already explained in details in the manuscript.

Some sections in the discussion seem to divert from the subject matter and introduce most the previously reported assertions

Thanks for the comment. These have been further read and edited

Yours Sincerely

Clovice Kankya

Attachments
Attachment
Submitted filename: rebuttal_auresp_2.docx
Decision Letter - Ayi Vandi Kwaghe, Editor

Gender perspectives on zoonotic disease epidemiology; A Strength Weakness Opportunities Threats analysis in Bundibugyo district, Uganda.

PONE-D-24-21886R2

Dear Dr. Kankya,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ayi Vandi Kwaghe, D.V.M., M.V.Sc., P.G.D.E. Ph.D., MPH, FETP

Academic Editor

PLOS ONE

Additional Editor Comments (optional): All comments were addressed by the authors.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Ayi Vandi Kwaghe, Editor

PONE-D-24-21886R2

PLOS ONE

Dear Dr. Kankya,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ayi Vandi Kwaghe

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .